Prevalence and associated risk factors of anemia among HIV infected children attending Gondar university hospital, Northwest Ethiopia: A cross sectional study

BMC Hematology

Volumn 15, Issue 1, 2015, Pages

  Enawgaw, Bamlaku ^a   Alem, Meseret ^a   Melku, Mulugeta ^a   Addis, Zelalem ^a   Terefe, Betelihem ^a   Yitayew, Gashaw ^b  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b Bahir Dar Health Science College   (Ethiopia)

Author keywords

Anemia; Children; HIV; Risk factors

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADOLESCENT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL VOLUME; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ETHIOPIA; FEMALE; FOOD INTAKE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTESTINE INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORMOCHROMIC NORMOCYTIC ANEMIA; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; STRUCTURED QUESTIONNAIRE; UNIVERSITY HOSPITAL; VIRUS LOAD;

EID: 85016309314     PISSN: None     EISSN: 20521839     Source Type: Journal    
DOI: 10.1186/s12878-015-0032-6     Document Type: Article

References (28)

1. Moore RD. Human immunodeficiency virus infection, anemia and survival. Clin Infect Dis. 1999;29:44-9.
2. Semba RD, Glenda EG. Pathogenesis of anaemia during human immunodeficiency virus infection. J Investig Med. 2001;49(3):225-39.
3. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system. Geneva: World Health Organization; 2011. (WHO/NMH/NHD/MNM/11.1). Available at http://www.who.int/vmnis/indicators/haemoglobin.pdf.
4. Alemu Y, Atomsa A, Sahlemariam Z. Hematology lecture notes for medical laboratory students. Jimma: Jimma University; 2006.
5. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity, WHO Technical report series No 405. Geneva: WHO; 1968.
6. WHO. Preventing and controlling iron deficiency anemia through primary health care. Geneva: WHO; 1989. p. 8.
7. Bruno de Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Geneva: WHO; 2008.
8. Volberding PA, Levin AM, Dieterich D. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38:1454-63.
9. Belperio PS, Rhew DC. Prevalence and outcomes of anaemia in individuals with human immunodefficiency virus: a systemic review of literature. AM J Med. 2004;116:27S-43S.
10. Mocroft A, Ole K, Barton SE. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS. 1999;13:943-50.
11. Clark TD, Mmiro F, Ndugwa C. Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda. Ann Trop Paediatr. 2002;22:11-7.
12. WHO. Focusing on anaemia: towards an integrated approach for effective anaemia control. Geneva: WHO; 2004.
13. De Maeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q. 1985;38:302-16.
14. Central Statistical Agency [Ethiopia], ICF International. Ethiopia demographic and health survey 2011. Addis Ababa, Ethiopia and Calverton, Maryland, USA: Central Statistical Agency and ICF International; 2012.
15. Brabin JB, Premji Z, Verhoeff F. Iron deficiency anaemia: reexamining the nature and magnitude of the public health problem. J Nutr. 2001;131:636S-48S.
16. Semba RD. Iron deficiency anemia and the cycle of poverty among human immunodeficiency virus infected women in the inner city. Clin Infect Dis. 2003;37:S105-11.
17. Moore RD, Forney D. Anaemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;29(1):54-7.
18. Muluneh A, Fessahaye A. Hematologic abnormalities among children on HAART in Jimma University specialized hospital, Southwestern Ethiopia. Ethiop J Health Sci. 2009;19(2):83-9.
19. Behler C, Shade S, Gregory K, Abrams D, Volberding P. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005;21(3):200-6.
20. Costello C. Haematological abnormalities in human immunodeficiency virus (HIV) disease. J Clin Pathol. 1988;41:711-5.
21. Lim P-L. HIV-related haematological conditions. Singapore: Tan Tock Seng Hospital; 2009.
22. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis. 2002;185:110-4.
23. Kreuzer K-A, Rockstroch JK. Pathogenesis and pathophysiology of anaemia in HIV-infection. Ann Hematol. 1997;75:179-87.
24. Shetn A, Mehta S, Rajagopalan N, Dinakar C, Ramesh E, Samuel NM, et al. Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr. 2009;9:37.
25. Eley BS, Sive AA, Shuttleworth M. A prospective cross-sectional study of anaemia and peripheral iron status in antiretral naive, HIV-1 infected children in Cape Town, South Africa. BMC Infect Dis. 2002;2:3.
26. Makubi NB, Mugusi F, Magesa MP, Roberts D, Quaresh A. Risk factors for anaemia among HIV infected children attending care and treatment clinic at Muhimbili national hospital in Dar es Salaam, Tanzania. Tanzan J Health Res. 2012;14(1):1-9.
27. Cardoso AM, Scopel KG, Muniz TP, Villamor E, Ferreira UM. Underlying factors associated with anemia in Amazonian children: a population-based, cross-sectional study. PLoS ONE. 2012;7(5):e36341.
28. Nyesigire RE, Bajunirwe F, Kiwanuka J. Anaemia in HIV-infected children: severity, types and effect on response to HAART. BMC Pediatr. 2012;12:170.